| __timestamp | Ligand Pharmaceuticals Incorporated | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12122000 | 22223073 |
| Thursday, January 1, 2015 | 13380000 | 6966842 |
| Friday, January 1, 2016 | 21221000 | 9000499 |
| Sunday, January 1, 2017 | 26887000 | 13741186 |
| Monday, January 1, 2018 | 27863000 | 19040000 |
| Tuesday, January 1, 2019 | 55908000 | 23559000 |
| Wednesday, January 1, 2020 | 59392000 | 31931000 |
| Friday, January 1, 2021 | 69012000 | 44981000 |
| Saturday, January 1, 2022 | 36082000 | 54234000 |
| Sunday, January 1, 2023 | 24537000 | 63806000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) is the lifeblood of innovation. Over the past decade, Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated have been at the forefront of this transformative journey. From 2014 to 2023, Viking Therapeutics has shown a remarkable upward trajectory in R&D spending, with a staggering 187% increase, peaking in 2023. This reflects their commitment to pioneering new therapies and expanding their pipeline.
Conversely, Ligand Pharmaceuticals, while maintaining a robust R&D budget, experienced a more fluctuating pattern. Their R&D expenses peaked in 2021, marking a 470% increase from 2014, before tapering off in subsequent years. This dynamic shift underscores the strategic pivots companies make in response to market demands and scientific breakthroughs. As these two biotech leaders continue to innovate, their R&D investments will undoubtedly shape the future of healthcare.
Comparing Innovation Spending: Merck & Co., Inc. and Ligand Pharmaceuticals Incorporated
Research and Development: Comparing Key Metrics for Pfizer Inc. and Ligand Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Comparing Innovation Spending: United Therapeutics Corporation and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Ligand Pharmaceuticals Incorporated
Research and Development Investment: Ligand Pharmaceuticals Incorporated vs MannKind Corporation
Analyzing R&D Budgets: Ligand Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.
R&D Insights: How Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds